In fact, in vitro and in vivo experiments have shown that COUP-TFII silencing inhibits cancer cell proliferation, reducing the number of cells in the S-phase and inducing cell apoptosis, increasing the expression of pro-apoptotic factors, including cytochrome C, BCL2 Associated X (BAX) and BRCA1 [173,174]. Here, NR2F2 is linked to cancer.